ChromaDex
CDXC
$3.78
Share price
0.53%
Change (1 day)
177.94%
Change (1 year)
Categories
Earnings for ChromaDex (CDXC)
Earnings in 2023 (TTM): -$4.94 M
According to ChromaDex's latest financial reports the company's current earnings (TTM) are -$4.94 M. In 2022 the company made an earning of -$16.54 M an increase over its 2021 earnings that were of -$27.13 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for ChromaDex from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$4.94 M | -70.15% |
| 2022 | -$16.54 M | -39.03% |
| 2021 | -$27.13 M | 36.15% |
| 2020 | -$19.93 M | -38.02% |
| 2019 | -$32.15 M | -3.51% |
| 2018 | -$33.32 M | 101.55% |
| 2017 | -$16.53 M | 470.57% |
| 2016 | -$2.9 M | 4.72% |
| 2015 | -$2.77 M | -48.66% |
| 2014 | -$5.39 M | 21.92% |
| 2013 | -$4.42 M | -62.08% |
| 2012 | -$11.66 M | 48.18% |
| 2011 | -$7.87 M | 289.87% |
| 2010 | -$2.02 M | 125.95% |
| 2009 | -$0.9 M | -54.35% |
| 2008 | -$1.96 M | 8290.97% |
| 2007 | -$0.03 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sangamo Therapeutics
SGMO | -$0.12 B | 2,309.72% | 🇺🇸 USA |
 Exelixis EXEL | $0.25 B | -5,315.09% | 🇺🇸 USA |